CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-18 | Thoma Jeanne Director | Sale | −6,865 | $89.76 | $616K | 38,080 |
| 2025-08-18 | Thoma Jeanne Director | Sale | −14,675 | $88.87 | $1.3M | 23,405 |
| 2025-08-18 | Leonard Matthew J Director | Sale | −6,937 | $88.17 | $612K | 9,392 |
| 2025-08-15 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale | −20,000 | $86.97 | $1.7M | 173,226 |
| 2025-08-15 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale | −52,990 | $87.15 | $4.6M | 531,920 |
| 2025-08-15 | Walsh Patrick D Director | Sale | −9,000 | $89.05 | $801K | 70,048 |
| 2025-08-14 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale | −47,010 | $89.48 | $4.2M | 584,910 |
| 2025-08-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $88.87 | $36K | 76,474 |
| 2025-08-12 | Gutwerg Ori SVP, GENERICS | Sale | −5,873 | $86.53 | $508K | 84,024 |
| 2025-08-12 | Lalwani Nikhil PRESIDENT & CEO | Sale | −56,960 | $85.93 | $4.9M | 411,219 |
| 2025-08-12 | CAREY STEPHEN P. SVP & CFO | Option exercise | +50,000 | $46.49 | $2.3M | 230,863 |
| 2025-08-12 | CAREY STEPHEN P. SVP & CFO | Sale | −50,000 | $86.07 | $4.3M | 180,863 |
| 2025-08-12 | CAREY STEPHEN P. SVP & CFO | Option exercise · Stock Option (right to buy) | −50,000 | $46.49 | $2.3M | 0 |
| 2025-08-12 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Sale | −4,975 | $85.71 | $426K | 40,794 |
| 2025-08-12 | HAUGHEY THOMAS Director | Sale | −19,341 | $85.93 | $1.7M | 36,521 |
| 2025-07-18 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for taxes | −2,071 | $66.30 | $137K | 76,874 |
| 2025-07-14 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $64.88 | $26K | 78,945 |
| 2025-06-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $61.37 | $25K | 79,345 |
| 2025-05-22 | Thoma Jeanne Director | Grant or award | +4,336 | 44,945 | ||
| 2025-05-22 | Leonard Matthew J Director | Grant or award | +4,336 | 16,329 |
Page 7 of 23 · 442 trades